Total Visits

Views
Subgroup analyses from an international, doubleblind, randomised, phase 3 trial evaluating the effect of denosumab on bone metastasis-free survival in men with castrate-resistant prostate cancer5

Select a period of time:

Views

Views
December 20230
January 20241
February 20240
March 20241
April 20240
May 20243
June 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States5
 

Top cities views

Views
Boardman1
Chicago1